Legal & General Group PLC Stoke Therapeutics, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 37,783 shares of STOK stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,783

Previous 31,077 21.58%

Holding current value

$1 Million

Previous $352,000 151.99%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$11.48 - $24.73 $76,984 - $165,839	6,706 Added 21.58%	37,783 $887,000
Q2 2025 Aug 12, 2025	SELL	$5.9 - $11.84 $25,193 - $50,556	-4,270 Reduced 12.08%	31,077 $352,000
Q4 2024 Feb 13, 2025	SELL	$10.8 - $13.92 $23,101 - $29,774	-2,139 Reduced 5.71%	35,347 $389,000
Q3 2024 Feb 28, 2025	SELL	$12.24 - $15.92 $18,849 - $24,516	-1,540 Reduced 4.36%	33,807 $415,000
Q3 2024 Nov 14, 2024	BUY	$12.24 - $15.92 $12,448 - $16,190	1,017 Added 2.79%	37,486 $460,000

Q2 2024 May 29, 2025	BUY	$11.03 - $17.52 $336,547 - $534,570	30,512 Added 1339.42%	32,790 $442,000
Q2 2024 Aug 14, 2024	BUY	$11.03 - $17.52 $377,126 - $599,026	34,191 Added 1500.92%	36,469 $492,000
Q1 2024 May 29, 2025	SELL	$4.12 - $14.17 $136,244 - $468,587	-33,069 Reduced 93.56%	2,278 $30,000
Q1 2024 May 14, 2024	SELL	$4.12 - $14.17 $3,506 - $12,058	-851 Reduced 27.2%	2,278 $30,000
Q4 2023 May 29, 2025	SELL	$3.37 - $5.4 $108,574 - $173,977	-32,218 Reduced 91.15%	3,129 $16,000
Q4 2023 Feb 15, 2024	SELL	$3.37 - $5.4 $26,302 - $42,147	-7,805 Reduced 71.38%	3,129 $16,000
Q3 2023 Nov 14, 2023	SELL	$3.78 - $11.99 $16,095 - $51,053	-4,258 Reduced 28.03%	10,934 $43,000
Q2 2023 Aug 14, 2023	BUY	$7.93 - $13.82 $94,930 - $165,439	11,971 Added 371.65%	15,192 $161,000
Q1 2023 May 15, 2023	SELL	$7.65 - $10.38 $23,539 - $31,939	-3,077 Reduced 48.86%	3,221 $26,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $13,263 - $23,791	1,056 Added 20.14%	6,298 $81,000
Q2 2022 Aug 22, 2022	SELL	$10.36 - $23.93 $404 - $933	-39 Reduced 0.74%	5,242 $69,000
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $525 - $890	29 Added 0.55%	5,281 $127,000
Q3 2021 Nov 15, 2021	BUY	$23.65 - $34.44 $59,881 - $87,202	2,532 Added 93.09%	5,252 $134,000
Q2 2021 Aug 12, 2021	BUY	$30.53 - $41.09 $21,828 - $29,379	715 Added 35.66%	2,720 $92,000
Q1 2021 May 17, 2021	BUY	$36.08 - $69.81 $7,937 - $15,358	220 Added 12.32%	2,005 $78,000
Q4 2020 Feb 12, 2021	SELL	$33.62 - $61.93 $18,659 - $34,371	-555 Reduced 23.72%	1,785 $110,000
Q3 2020 Nov 13, 2020	BUY	$22.23 - $37.48 $6,246 - $10,531	281 Added 13.65%	2,340 $79,000
Q2 2020 Aug 14, 2020	SELL	$20.26 - $29.73 $11,325 - $16,619	-559 Reduced 21.35%	2,059 $49,000
Q1 2020 May 14, 2020	BUY	$16.8 - $34.15 $13,708 - $27,866	816 Added 45.28%	2,618 $60,000
Q4 2019 Feb 13, 2020	BUY	$20.01 - $30.79 $6,243 - $9,606	312 Added 20.94%	1,802 $51,000
Q3 2019 Nov 13, 2019	BUY	$20.53 - $37.72 $30,589 - $56,202	1,490 New	1,490 $32,000

Others Institutions Holding STOK

# of Institutions

160

Shares Held

60.2M

Call Options Held

563K

Put Options Held

101K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $1.05B
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Stoke Therapeutics, Inc. Transaction History